References
- Brownlee WJ, Hardy TA, Fazekas F, Miller DH. Diagnosis of multiple sclerosis: progress and challenges. Lancet. 2017;389(10076):1336–1346. doi:10.1016/S0140-6736(16)30959-X.
- Gordon LK, Goldstein DA. Gender and uveitis in patients with multiple sclerosis. J Ophthalmol. 2014;2014:565262. doi:10.1155/2014/565262.
- Olsen TG, Frederiksen J. The association between multiple sclerosis and uveitis. Surv Ophthalmol. 2017;62(1):89–95. doi:10.1016/j.survophthal.2016.07.002.
- Toosy AT, Mason DF, Miller DH. Optic neuritis. Lancet Neurol. 2014;13(1):83–99. doi:10.1016/S1474-4422(13)70259-X.
- Barnes D, McDonald WI. The ocular manifestations of multiple sclerosis. 2. Abnormalities of eye movements. J Neurol Neurosurg Psychiatry. 1992;55(10):863–868. doi:10.1136/jnnp.55.10.863.
- Tilikete C, Jasse L, Vukusic S, et al. Persistent ocular motor manifestations and related visual consequences in multiple sclerosis. Ann N Y Acad Sci. 2011;1233(1):327–334. doi:10.1111/j.1749-6632.2011.06116.x.
- Biousse V, Trichet C, Bloch-Michel E, Roullet E. Multiple sclerosis associated with uveitis in two large clinic-based series. Neurology. 1999;52(1):179–181. doi:10.1212/WNL.52.1.179.
- Smith JR, Rosenbaum JT. Neurological concomitants of uveitis. Br J Ophthalmol. 2004;88(12):1498–1499. doi:10.1136/bjo.2003.040519.
- Zein G, Berta A, Foster CS. Multiple sclerosis-associated uveitis. Ocul Immunol Inflamm. 2004;12(2):137–142. doi:10.1080/09273940490895344.
- Tola MR, Granieri E, Casetta I, et al. Retinal periphlebitis in multiple sclerosis: a marker of disease activity? Eur Neurol. 1993;33(2):93–96. doi:10.1159/000116912.
- Arnold AC, Pepose JS, Hepler RS, Foos RY. Retinal periphlebitis and retinitis in multiple sclerosis. I Pathologic Characteristics Ophthalmol. 1984;91:255–262.
- AlBloushi AF, Dheyab AM, Al-Swaina NF, Al-Obailan M, Daif AK, Abu El-Asrar AM. Clinical findings and outcomes of uveitis associated with multiple sclerosis. Eur J Ophthalmol. 2021;31(2):482–490. doi:10.1177/1120672120904667.
- Wybar KC. The ocular manifestations of disseminated sclerosis. Proc R Soc Med. 1952;45:315–320.
- Graham EM, Francis DA, Sanders MD, Rudge P. Ocular inflammatory changes in established multiple sclerosis. J Neurol Neurosurg Psychiatry. 1989;52(12):1360–1363. doi:10.1136/jnnp.52.12.1360.
- Patte M, Rouher FN, Vernay D, Delaire JC, Bacin F. Proliferative retinal vasculitis and multiple sclerosis: a case report. J Fr Ophtalmol. 2003;26:381–385.
- Vine AK. Severe periphlebitis, peripheral retinal ischemia, and preretinal neovascularization in patients with multiple sclerosis. Am J Ophthalmol. 1992;113(1):28–32. doi:10.1016/S0002-9394(14)75748-4.
- Towler HM, Lightman S. Symptomatic intraocular inflammation in multiple sclerosis. Clin Exp Ophthalmol. 2000;28(2):97–102. doi:10.1046/j.1442-9071.2000.00270.x.
- Ronzani M, Lang GE, Wagner P, Lang GK. Severe occlusive retinal periphlebitis with vitreous hemorrhage in multiple sclerosis. Ger J Ophthalmol. 1995;4:328–331.
- Valentincic NV, Kraut A, Rothova A. Vitreous hemorrhage in multiple sclerosis-associated uveitis. Ocul Immunol Inflamm. 2007;15(1):19–25. doi:10.1080/09273940601147737.
- Turner SJ, Dharmasena A, Deane J. Bilateral rubeosis iridis and rubeotic glaucoma due to peripheral occlusive vasculitis associated with multiple sclerosis. Ocul Immunol Inflamm. 2011;19(5):373–375. doi:10.3109/09273948.2011.602500.
- Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of uveitis nomenclature working G. Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop. Am J Ophthalmol. 2005;140:509–516.
- Rucker CW. Sheathing of the retinal veins in multiple sclerosis. Review of pertinent literature. Mayo Clin Proc. 1972;47:335–340.
- Compston A. Lymphocyte subpopulations in patients with multiple sclerosis. J Neurol Neurosurg Psychiatry. 1983;46(2):105–114. doi:10.1136/jnnp.46.2.105.
- El-Asrar AM, Herbort CP, Tabbara KF. A clinical approach to the diagnosis of retinal vasculitis. Int Ophthalmol. 2010;30(2):149–173. doi:10.1007/s10792-009-9301-3.
- Huvard MJ, Pecen PE, Palestine AG. The clinical characteristics of noninfectious occlusive retinal vasculitis. Ophthalmol Retina. 2022 Jan;6(1):43–48. doi:10.1016/j.oret.2021.04.012. Epub 2021 Apr 24. PMID: 33901715.
- International Study Group for Behçet’s Disease. Criteria for diagnosis of Behçet’s disease. Lancet. 1990;335(8697): 1078–1080.
- Tugal-Tutkun I, Onal S, Stanford M, et al. An algorithm for the diagnosis of Behçet disease uveitis in adults. Ocul Immunol Inflamm. 2021 Aug 18;29(6):1154–1163. doi:10.1080/09273948.2020.1736310. Epub 2020 Apr 14. PMID: 32286112.
- Thompson AJ, Banwell BL, Barkhof F, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018;17(2):162–173. doi:10.1016/S1474-4422(17)30470-2.
- Barkhof F, Filippi M, Miller DH, et al. Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain. 1997;120(Pt 11):2059–2069. doi:10.1093/brain/120.11.2059.
- Akman-Demir G, Mutlu M, Kiyat-Atamer A, et al. Behçet’s disease patients with multiple sclerosis-like features: discriminative value of Barkhof criteria. Clin Exp Rheumatol. 2015;33:S80–84.
- Hedayatfar A, Falavarjani KG, Soheilian M, et al. Mycophenolate mofetil for the treatment of multiple sclerosis-associated uveitis. Ocul Immunol Inflamm. 2017;25(3):308–314. doi:10.1080/09273948.2016.1178302.
- Kaya D, Kaya M, Ozakbas S, Idiman E. Uveitis associated with multiple sclerosis: complications and visual prognosis. Int J Ophthalmol. 2014;7(6):1010–1013. doi:10.3980/j.2222-3959.2014.06.18.